Skip to main content

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservat

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservat

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Shionogi Protease Inhibitor

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Shionogi Protease Inhibitor

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • …
  • Next page Next
  • Last page Last
Subscribe to